Modernised tablet section of IDPL inaugurated at Gurgaon

Image
ANI Gurgaon
Last Updated : Aug 05 2015 | 6:42 PM IST

Union Minister of Chemicals and Fertilisers Ananth Kumar today inaugurated the modernised general tablet section of IDPL Gurgaon Plant.

Speaking on the occasion, Kumar said his department is working on 'Make-In-India' mantra, and this unit of IDPL is a step in that direction.

He assured the government's full support in enhancing the efficiency and productivity of public sector undertakings like IDPL.

Kumar said that providing affordable and good quality medicines to masses of the country is important and public sector undertakings have an important role to play as they are not driven by profit motive, but also serve public interest.

He assured that PSUs will not be sold. Instead, a model will be developed for leveraging their assets to make them financially sustainable.

Kumar said that a task force will be set up soon to look into all these aspects.

He said that his ministry is working in close coordination with other concerned departments of the government and state governments as Team India for attaining health security.

Kumar said that Jan Aushadhi will be revamped soon. He informed that Pharma Cluster, Pharma Parks and Medical Devices Parks are also a step in this direction.

The general tablet section of IDPL, Gurgaon Plant has been upgraded at the cost of Rs.3 crore as per "Revised Sch -M" requirement and GMP certificate has been obtained.

After modernization, this plant will be able to launch new products in the field of diabetes, oncology, NSAIDS, antibiotics-3rd Generation, nephrology and cardiology, including other segments of lifestyle diseases at affordable price and will play a vital role in providing the medicines at reasonable rate for the common people.

IDPL is one of the central public sector enterprises under the Department of Pharmaceuticals engaged in manufacturing and marketing of a large number of medicines for the masses.

The Minister of State for Chemicals and Fertilizers, Hansraj Gangaram Ahir, and Secretary, Department of Pharmaceuticals, Dr. V.K. Subburaj, were also present in the occasion.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 05 2015 | 6:28 PM IST

Next Story